by Nathaniel Weixel THE HILL Madeline Monroe/iStock/CDC via AP Federal regulators gave the green light to the first-ever vaccine to prevent the respiratory disease RSV on Wednesday, a major breakthrough that’s been decades in the making. The Food and Drug Administration (FDA) approved Arexvy, a shot developed by pharmaceutical giant GlaxoSmithKline (GSK) to prevent lower […]

The post First-Ever Vaccine to Prevent RSV In Older Adults Wins FDA Approval appeared first on The St Kitts Nevis Observer.